US3102132A - Esters of benzyloxycarbonylaminocyanoacetic acid and process - Google Patents

Esters of benzyloxycarbonylaminocyanoacetic acid and process Download PDF

Info

Publication number
US3102132A
US3102132A US87067A US8706761A US3102132A US 3102132 A US3102132 A US 3102132A US 87067 A US87067 A US 87067A US 8706761 A US8706761 A US 8706761A US 3102132 A US3102132 A US 3102132A
Authority
US
United States
Prior art keywords
acid
esters
pyrazolin
amino
benzyloxycarbonylaminocyanoacetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US87067A
Inventor
Noel F Albertson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Priority to US87067A priority Critical patent/US3102132A/en
Priority to US180917A priority patent/US3157670A/en
Application granted granted Critical
Publication of US3102132A publication Critical patent/US3102132A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Definitions

  • the invention in its composition aspect, resides in the concept of an ester of benzyloxycarbonylaminocyanoacetic acid useful as an intermediate for preparing a 3- amino-4-bcnzyloxycarbonyl amino-2-pyrazolin-5aone having a molecular structure represented by the following formula:
  • the above compound which is described and claimed in my copending application, Serial No. 180,917, filed February 23, 1962, which is a divisional application of the instant application, can be prepared by reacting hydrazine, preferably in the form of its hydrate, with an ester of a benzyloxycarbonylaminocyanoacetic acid, thereby to form a 3-amino-4-benzyloxycarbonylamino-Z-pyrazolin-S-one.
  • the phenyl radical in the molecular structure hereinbefore depicted can bear simple substitutents such as nitro, loweraalkyl containing from one to four carbon atoms, halo, triiluoromethyl, and lower-alkylsulfonyl, which we have found do not adversely affect the pharmacological activity of the structure for the above-stated purposes, and which are regarded by me as the whole equivalent of the compound wherein the phenyl ring is unsubstituted.
  • the compounds can conveniently be prepared by bringing together, for example, ethyl benzyloxycarbonylaminocyanoacetate and hydrazine or hydrazine hydrate in a suitable inert solvent, for example 95 percent ethanol. The reaction takes place at room temperature; but, if desired, the mixture can be warmed to facilitate dissolving the ethyl benzyloxycarbonylaminocyanoacetate.
  • the physical embodiments of the invention are colorless to light tan crystalline solids which are very slightly soluble in water and are soluble in dilute aqueous solutions of strong bases, for example, potassium hydroxide, sodium hydroxide, ammonium hydroxide, and the like.
  • the iollowing example serves to illustrate the best method known to the inventor for carrying out the invention.
  • EXAMPLE Ethyl Benzyloxycarbonylaminocyanoacetate "ice of ice were added 80.0 g. (1.22 moles) of zinc dust in one portion. Stirring was continued and after ten minutes 85.3 g. (0.5 mole) of carbobenzoxy chloride were added dropwise at a rather rapid rate. After thirty minutes, the product was collected on a filter and was washed with water. The crude yield was percent. After recrystallization irom ethyl acetate-hexane, the ethyl benzyloxycarbonylaminocyanoacetate melted at 116.0-116.9 C. (corn).
  • pyrazolones are known in the art which have utility as analgesics, antipyretics, an antiphlogistic agents.
  • the known pyrazolones which possess this utility contain phenyl, alkyl, or heterocyclic substituents on one or both of the ring nitrogen atoms. According to the instant invention, such substituents are now found not essential for producing active drugs.
  • 3- 1amino-4-benzy1oxycarbonylamino-2-pyrazolin-S-one set forth in the above example has been demonstrated to have analgesic activity in the range of that of aminopyrine by the radiant thermal stimulation test described by N. Ercoli and M. N. Lewis, J. Pharmacol. Exp. Therap, 84, 301 (1945).
  • the threshold dose was 200 rug/kg, and the maximum efiect occurred thirty minutes after administration.
  • Patented Aug. 27, 1963 2-pyrazolin-5-one, and the like.

Description

United States Patent 3,102,132 ESTERS 0F BENZYLOXYCARBONYLAMINO- CYANOACETIC ACID AND PROCESS Noel F. Albertson, East Greenbush, N.Y., assignor to Sterling Drug Inc, New York, N.Y., a corporation of Delaware No Drawing. Filed Feb. 6, 1961, Ser. No. 87,067 1 Claim. (Cl. 260-465) This invention relates to compositions of matter known in the art of chemistry as esters of acylaminocyanoacetic acid useful as intermediates for preparing Z-pyrazolin-S- ones and to processes for making the same.
The invention in its composition aspect, resides in the concept of an ester of benzyloxycarbonylaminocyanoacetic acid useful as an intermediate for preparing a 3- amino-4-bcnzyloxycarbonyl amino-2-pyrazolin-5aone having a molecular structure represented by the following formula:
The above compound, which is described and claimed in my copending application, Serial No. 180,917, filed February 23, 1962, which is a divisional application of the instant application, can be prepared by reacting hydrazine, preferably in the form of its hydrate, with an ester of a benzyloxycarbonylaminocyanoacetic acid, thereby to form a 3-amino-4-benzyloxycarbonylamino-Z-pyrazolin-S-one.
The phenyl radical in the molecular structure hereinbefore depicted can bear simple substitutents such as nitro, loweraalkyl containing from one to four carbon atoms, halo, triiluoromethyl, and lower-alkylsulfonyl, which we have found do not adversely affect the pharmacological activity of the structure for the above-stated purposes, and which are regarded by me as the whole equivalent of the compound wherein the phenyl ring is unsubstituted.
The compounds can conveniently be prepared by bringing together, for example, ethyl benzyloxycarbonylaminocyanoacetate and hydrazine or hydrazine hydrate in a suitable inert solvent, for example 95 percent ethanol. The reaction takes place at room temperature; but, if desired, the mixture can be warmed to facilitate dissolving the ethyl benzyloxycarbonylaminocyanoacetate.
The physical embodiments of the invention are colorless to light tan crystalline solids which are very slightly soluble in water and are soluble in dilute aqueous solutions of strong bases, for example, potassium hydroxide, sodium hydroxide, ammonium hydroxide, and the like.
The iollowing example serves to illustrate the best method known to the inventor for carrying out the invention.
EXAMPLE Ethyl Benzyloxycarbonylaminocyanoacetate "ice of ice were added 80.0 g. (1.22 moles) of zinc dust in one portion. Stirring was continued and after ten minutes 85.3 g. (0.5 mole) of carbobenzoxy chloride were added dropwise at a rather rapid rate. After thirty minutes, the product was collected on a filter and was washed with water. The crude yield was percent. After recrystallization irom ethyl acetate-hexane, the ethyl benzyloxycarbonylaminocyanoacetate melted at 116.0-116.9 C. (corn).
Analysis.Calcd. for C H N O N, 10.68; C. 59.52; H, 5.38. Found: -N, 10.85; C, 59.56; H, 5.31.
3-Amin0-4-Benzyloxycarbonylamina-2-Pyrwzolin-5-One To a solution of 13.1 g. (0.05 mole) of ethyl benzyloxycarbonylam-inocyanoacetate in 50 of ethanol were added 3.0 g. (0.05 mole) of percent hydrazine hydrate. The product soon began to crystallize. After standing for several days, 10.2 g. of product were collected ion a filter and were recrystallized from 50 ml. of acetic acid. The pale tan crystals of 3-amino-4-benzyloxycarbonylarnino-2-pyrazolin-5 one melted with decomposition at 2l7218 C. (cor-r).
Analysis.Calcd. for C H N O C, 53.21; H, 4.87; N, 22.57. Found: C, 53.02; H, 4.81; N, 22.45.
Numerous pyrazolones are known in the art which have utility as analgesics, antipyretics, an antiphlogistic agents. The known pyrazolones which possess this utility contain phenyl, alkyl, or heterocyclic substituents on one or both of the ring nitrogen atoms. According to the instant invention, such substituents are now found not essential for producing active drugs. For example, 3- 1amino-4-benzy1oxycarbonylamino-2-pyrazolin-S-one set forth in the above example has been demonstrated to have analgesic activity in the range of that of aminopyrine by the radiant thermal stimulation test described by N. Ercoli and M. N. Lewis, J. Pharmacol. Exp. Therap, 84, 301 (1945). Thus, when administered intraperitoneally to rats, the threshold dose was 200 rug/kg, and the maximum efiect occurred thirty minutes after administration.
Although the ethyl ester of benzyloxycarbonylaminocyanoacetate was used in the above example, it is obvious that other lower alkyl esters of the same acid, for example, the methyl, propyl, \and butyl esters, can be used in the same manner.
By replacing car-bobenzoxy chloride in the above example with the appropriately-substituted carbobenzoxy chloride, there can be prepared, for example,
3-amino-4- (4'-nitrobenzyloxycarb onyl amino) -2-pyrazolin-S -one,
3 -.amino-4- 4-methylbenzyloxycarbonylamino) -2-pyrazolin-S-one,
3 -arnino-4-( 4-bromobenzy1oxycarbonylamino) -2-pyraz- Olin-5 -one,
3 -amino-4- 2'-chlorobenzyloxycarbonyl amino) -2-pyrazolin-S -one,
3 amino-4- 4'-trifluoromethylbenzyloxycarbonylamino 2-pyraz-olin-5 -one,
3 -amin-o-4- (4'-methanesulfionylb enzyloxycarb onylamino 2-pyrazolin-5 -one,
3 -amino-4- 3 ,5 '-dirnethylbenzyloxycarbonylamino) -2- pyrazolin-S-one,
Patented Aug. 27, 1963 2-pyrazolin-5-one, and the like.
I claim: Ethyl benzyloxycarbonylaminocyanoacetate.
4 Pinson Sept. 22, 1959 Nowak Dec. 1, 1959 Schulze Mar. 8, 1960 FOREIGN PATENTS Sweden Dec. 11, 1951 OTHER REFERENCES Beilstein: Organische Chemie 1923, Band 6, p. 452.
(Copy in Sci. Library.)
References Cited in the file of this patent UNITED STATES PATENTS Lynn June 3, 1958 2,837,558 brary.
10 Ohta: Chem. Abstracts, vol. 48, column 4440 (1954). Bentley et a1.: Chem. Abstracts, vol. 44, volumn 4902 (1950). Copy available in Patent Ofiice Scientific Li
US87067A 1961-02-06 1961-02-06 Esters of benzyloxycarbonylaminocyanoacetic acid and process Expired - Lifetime US3102132A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US87067A US3102132A (en) 1961-02-06 1961-02-06 Esters of benzyloxycarbonylaminocyanoacetic acid and process
US180917A US3157670A (en) 1961-02-06 1962-02-23 3-amino-4-acylamino-2-pyrazolin-5-ones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87067A US3102132A (en) 1961-02-06 1961-02-06 Esters of benzyloxycarbonylaminocyanoacetic acid and process

Publications (1)

Publication Number Publication Date
US3102132A true US3102132A (en) 1963-08-27

Family

ID=22202921

Family Applications (1)

Application Number Title Priority Date Filing Date
US87067A Expired - Lifetime US3102132A (en) 1961-02-06 1961-02-06 Esters of benzyloxycarbonylaminocyanoacetic acid and process

Country Status (1)

Country Link
US (1) US3102132A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506702A (en) * 1966-01-03 1970-04-14 Knoll Ag 2-cyanoalkyl urethanes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2837558A (en) * 1953-04-22 1958-06-03 Union Carbide Corp Esters of n, nu-bis(2-cyanoethyl) carboxamic acids
US2905694A (en) * 1959-09-22 Certain esters of i
US2915549A (en) * 1958-09-24 1959-12-01 Dow Chemical Co Process for preparing 1-cyano-2-chloroethyl acetate
US2927928A (en) * 1958-02-06 1960-03-08 Gen Aniline & Film Corp Production of 3-n-monosubstituted amino-1-aryl-5-pyrazolones

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2905694A (en) * 1959-09-22 Certain esters of i
US2837558A (en) * 1953-04-22 1958-06-03 Union Carbide Corp Esters of n, nu-bis(2-cyanoethyl) carboxamic acids
US2927928A (en) * 1958-02-06 1960-03-08 Gen Aniline & Film Corp Production of 3-n-monosubstituted amino-1-aryl-5-pyrazolones
US2915549A (en) * 1958-09-24 1959-12-01 Dow Chemical Co Process for preparing 1-cyano-2-chloroethyl acetate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506702A (en) * 1966-01-03 1970-04-14 Knoll Ag 2-cyanoalkyl urethanes

Similar Documents

Publication Publication Date Title
US3388129A (en) 1-methyl ergot alkaloids
EP0028833A2 (en) Imidazole derivatives, their production and use
US3567765A (en) N-aromatic substituted acid amides and esters
US3560566A (en) Diphenyl-ureas,-thioureas,-guanidines and -parabanic acids
US3404152A (en) Substituted pyridyl urea compounds
US3102132A (en) Esters of benzyloxycarbonylaminocyanoacetic acid and process
US2877269A (en) Guanyl substituted triphenylethanes, triphenylethylenes and benzalfluorenes
US2844510A (en) Phosphoric acid derivatives of 1-phenyl-2, 3-dimethyl-4-amino-5-pyrazolone
US3799988A (en) {107 -guanidino acid diamide derivatives and manufacturing the same
US2740788A (en) J-hydroxy-n-propargyl-morphinanes
US3876655A (en) Anti-inflammatory acyl imidazoles
US3157670A (en) 3-amino-4-acylamino-2-pyrazolin-5-ones
US3179665A (en) 9-(n-ethyl and n-propyl piperidyl-3'-methyl)-thioxanthenes
JPS6019748B2 (en) Production method of isoindoline derivatives
US2767192A (en) Ketone hydrazones
US3705920A (en) Sulfonylphenylphosphonic acids
US2905590A (en) Thioxanthene derivative
US3426017A (en) Sulfonylurea compounds
US3301852A (en) 1-hydroxymethyl-colchicine and derivatives thereof
US3624094A (en) Alpha-{8 (phenyl sulfinyl)methyl{9 -alpha-phenyl derivatives of pyridinemethanols
US2397903A (en) Methylene-bis-2 hydroxy-3 naphthoates
US4041072A (en) Acetamidoxime compounds
US3270020A (en) Dihydro ergocornine
US2649456A (en) Alpha, alpha-diphenyl-gamma-(nu-methyl-2-piperidyl)-butyramides and acid addition and quaternary ammonium derivatives thereof
US3607881A (en) Phenylbutazone derivatives